Streamline Health Solutions, Inc. (NASDAQ:STRM) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Wednesday. The brokerage currently has a $1.25 target price on the stock. Zacks Investment Research‘s price target would suggest a potential upside of 21.36% from the company’s current price.

According to Zacks, “Streamline Health Solutions, Inc. is a leading supplier of workflow and document management tools, applications and services that assist strategic business partners and healthcare organizations to improve operational efficiencies through business process optimization. The Company provides integrated tools and technologies for automating document-intensive environments, including document workflow, document management, e-forms, portal connectivity, optical character recognition and interoperability. The Company’s workflow-based services offer solutions to inefficient and labor-intensive healthcare business processes throughout the revenue cycle, such as chart coding, abstracting and completion, remote physician order processing, pre-admission registration scanning and signature capture, insurance verification, secondary billing services, explanation of benefits processing and release of information processing. “

Separately, ValuEngine cut Streamline Health Solutions from a “sell” rating to a “strong sell” rating in a report on Wednesday, May 17th.

Streamline Health Solutions (NASDAQ:STRM) opened at 1.03 on Wednesday. Streamline Health Solutions has a 52 week low of $0.85 and a 52 week high of $2.11. The company’s market cap is $20.29 million. The stock has a 50 day moving average of $1.24 and a 200 day moving average of $1.27.

Streamline Health Solutions (NASDAQ:STRM) last released its quarterly earnings results on Monday, June 12th. The company reported ($0.10) earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.10). The company had revenue of $5.92 million for the quarter. Streamline Health Solutions had a negative return on equity of 47.51% and a negative net margin of 21.76%. Equities research analysts predict that Streamline Health Solutions will post ($0.25) earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This article was first published by American Banking News and is owned by of American Banking News. If you are reading this article on another website, it was illegally stolen and reposted in violation of international trademark & copyright laws. The legal version of this article can be accessed at https://www.americanbankingnews.com/2017/06/21/streamline-health-solutions-inc-strm-rating-increased-to-buy-at-zacks-investment-research.html.

In other news, SVP Shaun Linwood Priest purchased 21,000 shares of Streamline Health Solutions stock in a transaction dated Thursday, April 13th. The shares were bought at an average cost of $1.25 per share, for a total transaction of $26,250.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Over the last 90 days, insiders have bought 56,000 shares of company stock worth $65,750. Company insiders own 26.10% of the company’s stock.

Hedge funds have recently added to or reduced their stakes in the company. Renaissance Technologies LLC boosted its stake in shares of Streamline Health Solutions by 17.8% in the first quarter. Renaissance Technologies LLC now owns 278,895 shares of the company’s stock valued at $284,000 after buying an additional 42,195 shares during the last quarter. Nantahala Capital Management LLC bought a new stake in shares of Streamline Health Solutions during the third quarter valued at approximately $1,273,000. Great Point Partners LLC bought a new stake in shares of Streamline Health Solutions during the third quarter valued at approximately $279,000. Emerald Acquisition Ltd. bought a new stake in shares of Streamline Health Solutions during the second quarter valued at approximately $211,000. Finally, First Light Asset Management LLC boosted its stake in shares of Streamline Health Solutions by 38.6% in the fourth quarter. First Light Asset Management LLC now owns 1,739,045 shares of the company’s stock valued at $2,452,000 after buying an additional 483,897 shares during the last quarter. Institutional investors own 52.04% of the company’s stock.

Streamline Health Solutions Company Profile

Streamline Health Solutions, Inc is engaged in providing healthcare information technology through the licensing of its Electronic Health Information Management, Patient Financial, Coding and Clinical Documentation Improvement (CDI), and other Workflow software applications, and the use of such applications by software as a service.

Get a free copy of the Zacks research report on Streamline Health Solutions (STRM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Streamline Health Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Streamline Health Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.